Login to Your Account

NewCo News

PhenoMatriX Targets 'Matrix' of Cancer-Causing Events

By Marie Powers
Staff Writer

Friday, March 23, 2012
Privately held biotech PhenoMatriX Inc. (PMX) isn't yet ready for prime time, and company president and CEO Kosta Steliou is loath to suggest a commercialization timetable.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription